Jentashapir Journal of Health Research

Published by: Kowsar
Uncorrected Proof scheduled for 8 (6)

The Effect of Sodium Selenite on the Acute Phase Protein Response and Plasma Variables in Patients Admitted in ICU

Behzad Kazemi Haki 1 , Seyyed Reza Moaddab 2 , Mohammad Reza Rafii 3 , Mohammad Eftekhari 4 , Shdieh Lebadi 5 , Nasser Ghorbaniyan 6 and Keivan Amini 7 , *
Authors Information
1 Department of Anesthesiology, Mahabad Imam Khomeini Hospital, Urmia University of Medical Sciences, Urmia, IR Iran
2 School of Paramedical, Tabriz University of Medical Sciences, Tabriz, IR Iran
3 Department of Anesthesiology, AJA University of Medical Sciences, Tehran, IR Iran
4 School of Medicine, Iran University of Medical Sciences, Student Research Committee, Tehran, IR Iran
5 MSc of Mental Health Nursing Education, Mahabad Imam Khomeini Hospital, Urmia University of Medical Sciences, Urmia, IR Iran
6 Department of Anesthesiology, School of Paramedical Sciences, Tabriz University of Medical Sciences, Tabriz, IR Iran
7 Student of Medicine, School of Medicine, Student Research Committee, Tabriz University of Medical Sciences, Tabriz, IR Iran
Article information
  • Jentashapir Journal of Health Research: , In Press (In Press); e65647
  • Published Online: December 31, 2017
  • Article Type: Research Article
  • Received: December 1, 2017
  • Accepted: December 15, 2017
  • DOI: 10.5812/jjhr.65647

To Cite: Kazemi Haki B, Moaddab S R, Rafii M R, Eftekhari M, Lebadi S, et al. The Effect of Sodium Selenite on the Acute Phase Protein Response and Plasma Variables in Patients Admitted in ICU, Jentashapir J Helath Res. Online ahead of Print ;In Press(In Press):e65647. doi: 10.5812/jjhr.65647.

Abstract
Copyright © 2018, Jentashapir Journal of Health Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
References
  • 1. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805-12. doi: 10.1172/JCI18921. [PubMed: 12813013]. [PubMed Central: PMC161431].
  • 2. Arupconsult. Acute Phase Inflammatory Proteins - Acute Phase Reactants. 2015. Available from: http://www.arupconsult.com/index.html.
  • 3. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af. [PubMed: 23353941].
  • 4. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546-54. doi: 10.1056/NEJMoa022139. [PubMed: 12700374].
  • 5. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303-10. [PubMed: 11445675].
  • 6. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 2007;35(5):1244-50. doi: 10.1097/01.CCM.0000261890.41311.E9. [PubMed: 17414736].
  • 7. Dellinger RP. Cardiovascular management of septic shock. Crit Care Med. 2003;31(3):946-55. doi: 10.1097/01.CCM.0000057403.73299.A6. [PubMed: 12627010].
  • 8. Linde-Zwirble WT, Angus DC. Severe sepsis epidemiology: sampling, selection, and society. Crit Care. 2004;8(4):222-6. doi: 10.1186/cc2917. [PubMed: 15312201]. [PubMed Central: PMC522859].
  • 9. Heyland DK, Dhaliwal R, Suchner U, Berger MM. Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med. 2005;31(3):327-37. doi: 10.1007/s00134-004-2522-z. [PubMed: 15605227].
  • 10. Angstwurm MWA, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, et al. Selenium in Intensive Care (SIC): Results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock*. Critical Care Medicine. 2007;35(1):118-26. doi: 10.1097/01.ccm.0000251124.83436.0e.
  • 11. Schomburg L, Schweizer U, Kohrle J. Selenium and selenoproteins in mammals: extraordinary, essential, enigmatic. Cell Mol Life Sci. 2004;61(16):1988-95. doi: 10.1007/s00018-004-4114-z. [PubMed: 15316649].
  • 12. Burk RF, Hill KE, Motley AK. Selenoprotein metabolism and function: evidence for more than one function for selenoprotein P. J Nutr. 2003;133(5 Suppl 1):1517S-20S. doi: 10.1093/jn/133.5.1517S. [PubMed: 12730456].
  • 13. Birringer M, Pilawa S, Flohe L. Trends in selenium biochemistry. Nat Prod Rep. 2002;19(6):693-718. [PubMed: 12521265].
  • 14. Dodig S, Cepelak I. The facts and controversies about selenium. Acta Pharm. 2004;54(4):261-76. [PubMed: 15634611].
  • 15. Darlow BA, Austin NC. Selenium supplementation to prevent short-term morbidity in preterm neonates. Cochrane Database Syst Rev. 2003;(4). CD003312. doi: 10.1002/14651858.CD003312. [PubMed: 14583967].
  • 16. Darlow BA, Winterbourn CC, Inder TE, Graham PJ, Harding JE, Weston PJ, et al. The effect of selenium supplementation on outcome in very low birth weight infants: a randomized controlled trial. The New Zealand Neonatal Study Group. J Pediatr. 2000;136(4):473-80. [PubMed: 10753245].
  • 17. Sligl WI, Milner DJ, Sundar S, Mphatswe W, Majumdar SR. Safety and efficacy of corticosteroids for the treatment of septic shock: A systematic review and meta-analysis. Clin Infect Dis. 2009;49(1):93-101. doi: 10.1086/599343. [PubMed: 19489712].
  • 18. Patel GP, Balk RA. Systemic steroids in severe sepsis and septic shock. Am J Respir Crit Care Med. 2012;185(2):133-9. doi: 10.1164/rccm.201011-1897CI. [PubMed: 21680949].
  • 19. Berger MM, Soguel L, Shenkin A, Revelly JP, Pinget C, Baines M, et al. Influence of early antioxidant supplements on clinical evolution and organ function in critically ill cardiac surgery, major trauma, and subarachnoid hemorrhage patients. Crit Care. 2008;12(4):R101. doi: 10.1186/cc6981. [PubMed: 18687132]. [PubMed Central: PMC2575590].
  • 20. Salama A, Sakr Y, Reinhart K. The role of selenium in critical illness: basic science and clinical implications. Indian JCrit Care Med. 2007;11(3):127.
  • 21. Giamarellos-Bourboulis EJ, Giannopoulou P, Grecka P, Voros D, Mandragos K, Giamarellou H. Should procalcitonin be introduced in the diagnostic criteria for the systemic inflammatory response syndrome and sepsis? J Crit Care. 2004;19(3):152-7. [PubMed: 15484175].
  • 22. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med. 2006;34(7):1996-2003. doi: 10.1097/01.CCM.0000226413.54364.36. [PubMed: 16715031].
  • 23. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis. 2007;7(3):210-7. doi: 10.1016/S1473-3099(07)70052-X. [PubMed: 17317602].
  • 24. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA. 2004;292(19):2357-65. doi: 10.1001/jama.292.19.2357. [PubMed: 15547163].
  • 25. Murphy DJ, Hope PL, Johnson A. Neonatal risk factors for cerebral palsy in very preterm babies: case-control study. BMJ. 1997;314(7078):404-8. [PubMed: 9040385]. [PubMed Central: PMC2125924].
  • 26. Jafari AH, Bilan N, Taghizadieh A, Tahmasebi S, Navidi P. Factors that affect the outcomes in children with decompensated shock. Med J Tabriz Univ Med Sci. 2012;34(2):26-30.
  • 27. Forceville X, Laviolle B, Annane D, Vitoux D, Bleichner G, Korach JM, et al. Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study. Crit Care. 2007;11(4):R73. doi: 10.1186/cc5960. [PubMed: 17617901]. [PubMed Central: PMC2206523].
  • 28. Neve J. Selenium as a risk factor for cardiovascular diseases. J Cardiovasc Risk. 1996;3(1):42-7. [PubMed: 8783029].
  • 29. Salonen JT, Salonen R, Seppanen K, Kantola M, Parviainen M, Alfthan G, et al. Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in Eastern Finnish men. Atherosclerosis. 1988;70(1-2):155-60. [PubMed: 3258519].
  • 30. Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, Dasta JF, et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med. 2004;32(9):1928-48. [PubMed: 15343024].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments